Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY
The primary goal is to determine if Dipyridamole can improve serum phosphate levels and reduce the need for phosphate supplementation.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Adult kidney transplant patients.
• No known contraindications to Dipyridamole
Locations
United States
California
Stanford University
RECRUITING
Stanford
Time Frame
Start Date: 2025-05-15
Estimated Completion Date: 2027-05
Participants
Target number of participants: 90
Treatments
Experimental: Treatment Group
Participants receive Dipyridamole in addition to standard post-transplant care.
No_intervention: Control Group
Participants in this group will receive standard post-transplant care without Dipyridamole.
Related Therapeutic Areas
Sponsors
Leads: Stanford University